199 related articles for article (PubMed ID: 31221742)
21. A Longitudinal Analysis Reveals Early Activation and Late Alterations in B Cells During Primary HIV Infection in Mozambican Adults.
Jiménez M; Pastor L; Urrea V; Rodríguez de la Concepción ML; Parker E; Fuente-Soro L; Jairoce C; Mandomando I; Carrillo J; Naniche D; Blanco J
Front Immunol; 2020; 11():614319. PubMed ID: 33519823
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of CXCR5 in CD27- B cells of HIV-1 infected patients.
Chong Y; Nabeshima S; Furusyo N; Murata M; Yamaji K; Hayashi J
J Med Virol; 2004 Jul; 73(3):362-7. PubMed ID: 15170629
[TBL] [Abstract][Full Text] [Related]
23. Persistence of a large population of exhausted monoclonal B cells in mixed cryoglobuliemia after the eradication of hepatitis C virus infection.
Visentini M; Conti V; Cagliuso M; Siciliano G; Scagnolari C; Casato M; Fiorilli M
J Clin Immunol; 2012 Aug; 32(4):729-35. PubMed ID: 22382878
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression.
Kim ES; Ackermann C; Tóth I; Dierks P; Eberhard JM; Wroblewski R; Scherg F; Geyer M; Schmidt RE; Beisel C; Bockhorn M; Haag F; van Lunzen J; Schulze Zur Wiesch J
J Leukoc Biol; 2017 May; 101(5):1263-1271. PubMed ID: 28193736
[TBL] [Abstract][Full Text] [Related]
25. Identification of a CD21 receptor-deficient, non-Ig-secreting peripheral B lymphocyte subset in HIV-seropositive drug abusers.
Benedetto A; Di Caro A; Camporiondo MP; Gallone D; Zaniratti S; Tozzi V; Elia G
Clin Immunol Immunopathol; 1992 Feb; 62(2):139-47. PubMed ID: 1370396
[TBL] [Abstract][Full Text] [Related]
26. The controversial impact of B cells subsets on immune response to pneumococcal vaccine in HIV-1 patients.
Tsachouridou O; Skoura L; Zebekakis P; Margariti A; Georgiou A; Daniilidis M; Malisiovas N; Metallidis S
Int J Infect Dis; 2015 Sep; 38():24-31. PubMed ID: 26192868
[TBL] [Abstract][Full Text] [Related]
27. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
28. Increased frequency of CD27- (naive) B cells and their phenotypic alteration in HIV type 1-infected patients.
Chong Y; Ikematsu H; Yamamoto M; Murata M; Yamaji K; Nishimura M; Nabeshima S; Kashiwagi S; Hayashi J
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):621-9. PubMed ID: 15242538
[TBL] [Abstract][Full Text] [Related]
29. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones.
Isnardi I; Ng YS; Menard L; Meyers G; Saadoun D; Srdanovic I; Samuels J; Berman J; Buckner JH; Cunningham-Rundles C; Meffre E
Blood; 2010 Jun; 115(24):5026-36. PubMed ID: 20231422
[TBL] [Abstract][Full Text] [Related]
30. Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection.
Hejdeman B; Lenkei R; Leandersson AC; Hultström AL; Wahren B; Sandström E; Bratt G
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):277-86. PubMed ID: 11242515
[TBL] [Abstract][Full Text] [Related]
31. CD21/CD35 in B cell activation.
Carroll MC
Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
[TBL] [Abstract][Full Text] [Related]
32. Human marginal zone B cells are not an activated B cell subset: strong expression of CD21 as a putative mediator for rapid B cell activation.
Timens W; Boes A; Poppema S
Eur J Immunol; 1989 Nov; 19(11):2163-6. PubMed ID: 2532141
[TBL] [Abstract][Full Text] [Related]
33. The Antigen Presenting Potential of CD21
Reincke ME; Payne KJ; Harder I; Strohmeier V; Voll RE; Warnatz K; Keller B
Front Immunol; 2020; 11():535784. PubMed ID: 33193306
[TBL] [Abstract][Full Text] [Related]
34. Concerted effect of lymphopenia, viraemia and T-cell activation on Fas expression of peripheral B cells in HIV-1-infected patients.
Rethi B; Sammicheli S; Amu S; Pensieroso S; Hejdeman B; Schepis D; Thang PH; Chiodi F
AIDS; 2013 Jan; 27(2):155-62. PubMed ID: 23238551
[TBL] [Abstract][Full Text] [Related]
35. CD27 expression in the human splenic marginal zone: the infant marginal zone is populated by naive B cells.
Zandvoort A; Lodewijk ME; de Boer NK; Dammers PM; Kroese FG; Timens W
Tissue Antigens; 2001 Oct; 58(4):234-42. PubMed ID: 11782274
[TBL] [Abstract][Full Text] [Related]
36. Naive- and Memory-like CD21
Freudenhammer M; Voll RE; Binder SC; Keller B; Warnatz K
J Immunol; 2020 Oct; 205(8):2016-2025. PubMed ID: 32907998
[TBL] [Abstract][Full Text] [Related]
37. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals.
Moir S; Ho J; Malaspina A; Wang W; DiPoto AC; O'Shea MA; Roby G; Kottilil S; Arthos J; Proschan MA; Chun TW; Fauci AS
J Exp Med; 2008 Aug; 205(8):1797-805. PubMed ID: 18625747
[TBL] [Abstract][Full Text] [Related]
38. Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function.
Lange CG; Xu Z; Patterson BK; Medvik K; Harnisch B; Asaad R; Valdez H; Lee SJ; Landay A; Lieberman J; Lederman MM
AIDS; 2004 Mar; 18(4):605-13. PubMed ID: 15090765
[TBL] [Abstract][Full Text] [Related]
39. Impact of HIV infection and highly active antiretroviral therapy (HAART) on B cell subpopulations in children.
Singh R; Mukherjee A; Singla M; Vajpayee M; Negi N; Kabra SK; Lodha R; Das BK
J Med Virol; 2018 Jul; 90(7):1222-1231. PubMed ID: 29575050
[TBL] [Abstract][Full Text] [Related]
40. Role of complement receptors CD21/CD35 in B lymphocyte activation and survival.
Carroll M
Curr Top Microbiol Immunol; 1999; 246():63-8; discussion 69. PubMed ID: 10396040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
